Understanding how a protein helps prevent neurodegeneration

Unraveling the role of the molecular co-chaperone DNAJC7 in protein homeostasis and neurodegeneration

NIH-funded research University of California, San Francisco · NIH-10984366

This study is looking at how a protein called DNAJC7 helps keep other proteins from misfolding, which can cause brain diseases like Alzheimer's and Huntington's, to see if understanding this can lead to new treatments for these conditions.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco NIH-funded
Lab location1 site (San Francisco, United States)
Project IDNIH-10984366 on NIH RePORTER

What this research studies

This research investigates the role of a protein called DNAJC7 in preventing the misfolding of other proteins that can lead to neurodegenerative diseases like Alzheimer's and Huntington's disease. By using advanced techniques such as CRISPR, the researchers aim to understand how DNAJC7 functions in neurons and its potential to inhibit the aggregation of harmful proteins. The study will explore how changes in DNAJC7 expression affect disease symptoms in models of neurodegeneration, providing insights into new therapeutic strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with neurodegenerative diseases such as Alzheimer's or Huntington's disease.

Not a fit: Patients with neurodegenerative conditions not related to protein misfolding may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that slow down or prevent neurodegenerative diseases.

How similar studies have performed: Other research has shown promise in targeting protein misfolding in neurodegenerative diseases, suggesting that this approach could be effective.

Where this research is happening

San Francisco, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAmyotrophic Lateral Sclerosis Motor Neuron Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.